What did Amedisys, Inc. pay for Asana Hospice?

Amedisys, Inc. acquired Asana Hospice for $65.6M in 2020 (13.2x EBITDA), equivalent to 2.30x revenue. Target revenue was approximately $28.0M. Target EBITDA was approximately $5.0M.

What does Asana Hospice do?

Asana Hospice is a hospice business.

What multiple did Amedisys, Inc. pay for Asana Hospice?

13.2x EBITDA and 2.30x revenue, based on disclosed deal value of $65.6M and disclosed financials.

M&A TRANSACTION · 2020

Asana Hospice acquired by Amedisys, Inc.

$65.6M· 13.2x EBITDA· 2.30x revenue

Target

Asana Hospice

Acquirer

Amedisys, Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$28.0M

EBITDA

$5.0M

Deal Value

$65.6M

EV/EBITDA

13.2x

Context

This $65.6M acquisition of Asana Hospice by Amedisys, Inc. sits in the hospice sub-vertical. The 13.2x EBITDA multiple paid in 2020 can be compared against the population median for hospice transactions of similar size on our Hospice valuation hub. Amedisys, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price hospice businesses on our Hospice strategic buyer-pool page.

Source

Data sourced from SEC filings and cost reports. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own hospice

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Asana Hospice acquisition.

Citation: ExitValue.ai. (2020). Asana Hospice acquired by Amedisys, Inc.. https://exitvalue.ai/deals/asana-hospice-acquired-by-amedisys-inc-hc-2020-0134